• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者 Erdheim-Chester 病报告,表现为神经内分泌症状,BRAF 突变阴性。

Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for BRAF mutation.

机构信息

Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China.

Department of Pathology, The First Hospital of Jilin University, Changchun, Jilin, China.

出版信息

Medicine (Baltimore). 2023 May 19;102(20):e33846. doi: 10.1097/MD.0000000000033846.

DOI:10.1097/MD.0000000000033846
PMID:37335698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10194594/
Abstract

RATIONALE

Erdheim-Chester disease (ECD) is a rare progressive disease affecting multiple systems. It has recently been recognized as a neoplastic disease following the discovery of activating mutations in the MAPK pathway. There are several striking signs of ECD, such as the long bone involvement, as well as the hairy kidney appearance on computed tomography scan. It is rare for ECD to manifest neurological symptoms. Central nervous system involvement is a strong prognostic factor and independent predictor of death. ECD is characterized by the overproduction and accumulation of foamy histiocytes and Touton's giant cells in various tissues and organs. ECD is a multisystem disorder in which any organ may be affected.

PATIENT CONCERNS

This case report describes a 57-year-old woman with headaches and ataxia as the first clinical manifestation, without characteristic bone pain, but with delayed enuresis. In addition to the renal involvement, this patient had rarer splenic involvement.

DIAGNOSES

The imaging presentation of this patient was similar to that of a "multiple meningiomas". A combination of clinical, imaging and pathology for the diagnosis of ECD.

INTERVENTIONS

Patients were given INF-α therapy.

OUTCOMES

Fortunately, the patient responded well to INF-α treatment.

LESSONS

ECD patient with neuro-endocrine symptoms.

摘要

背景

Erdheim-Chester 病(ECD)是一种影响多系统的罕见进行性疾病。在发现 MAPK 通路的激活突变后,它最近被认为是一种肿瘤性疾病。ECD 有几个显著的特征,如长骨受累,以及计算机断层扫描(CT)上的“多毛肾”外观。ECD 表现出神经系统症状较为罕见。中枢神经系统受累是一个强烈的预后因素和独立的死亡预测因素。ECD 的特征是在各种组织和器官中过度产生和积累泡沫状组织细胞和 Touton 巨细胞。ECD 是一种多系统疾病,任何器官都可能受到影响。

病例介绍

本病例报告描述了一位 57 岁女性,以头痛和共济失调为首发临床表现,无特征性骨痛,但有遗尿延迟。除了肾脏受累外,该患者还有更罕见的脾脏受累。

诊断

该患者的影像学表现类似于“多发脑膜瘤”。综合临床、影像学和病理学表现诊断为 ECD。

治疗

患者接受了 INF-α 治疗。

结果

幸运的是,患者对 INF-α 治疗反应良好。

结论

ECD 患者伴有神经内分泌症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314e/10194594/51c076b78dde/medi-102-e33846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314e/10194594/7267ece45ab8/medi-102-e33846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314e/10194594/7f99e67cbb28/medi-102-e33846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314e/10194594/48902102344a/medi-102-e33846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314e/10194594/51c076b78dde/medi-102-e33846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314e/10194594/7267ece45ab8/medi-102-e33846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314e/10194594/7f99e67cbb28/medi-102-e33846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314e/10194594/48902102344a/medi-102-e33846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/314e/10194594/51c076b78dde/medi-102-e33846-g004.jpg

相似文献

1
Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for BRAF mutation.患者 Erdheim-Chester 病报告,表现为神经内分泌症状,BRAF 突变阴性。
Medicine (Baltimore). 2023 May 19;102(20):e33846. doi: 10.1097/MD.0000000000033846.
2
Erdheim-Chester disease.额颞叶痴呆。
Blood. 2020 Apr 16;135(16):1311-1318. doi: 10.1182/blood.2019002766.
3
The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.组织细胞增多症厄尔布-切斯特病是一种炎性髓系肿瘤。
Expert Rev Clin Immunol. 2015;11(9):1033-42. doi: 10.1586/1744666X.2015.1060857. Epub 2015 Jul 21.
4
Clinical and Neuroimaging Manifestations of Erdheim-Chester Disease: A Review. Erdheim-Chester 病的临床和神经影像学表现:综述。
J Neuroimaging. 2021 Jan;31(1):35-44. doi: 10.1111/jon.12785. Epub 2020 Sep 13.
5
Erdheim-Chester disease.厄尔德海姆-切斯特病
Curr Rheumatol Rep. 2014 Apr;16(4):412. doi: 10.1007/s11926-014-0412-0.
6
Multisystem Erdheim-Chester disease presenting with pericardial effusion confirmed by the effusion cytology specimen.多发系统 Erdheim-Chester 病伴发的心包积液,经积液细胞学标本证实。
Cardiovasc Pathol. 2024 May-Jun;70:107625. doi: 10.1016/j.carpath.2024.107625. Epub 2024 Feb 28.
7
Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAF and KRAS Mutations: A Case Report.恩考芬尼与比美替尼联合治疗同时存在BRAF和KRAS突变的 Erdheim-Chester病的疗效:病例报告
Cancer Rep (Hoboken). 2024 Dec;7(12):e70093. doi: 10.1002/cnr2.70093.
8
Hypoalphalipoproteinemia and BRAF Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.低α脂蛋白血症和 BRAF 突变是 Erdheim-Chester 病主动脉浸润的主要预测因子。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1913-1925. doi: 10.1161/ATVBAHA.118.310803.
9
Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature.1例伯基特淋巴瘤患者合并厄尔德海姆-切斯特病:病例报告及文献复习
Diagn Pathol. 2018 Nov 24;13(1):94. doi: 10.1186/s13000-018-0772-2.
10
Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.累及乳腺的 Erdheim-Chester 病——一种罕见但重要的鉴别诊断。
Hum Pathol. 2015 Jan;46(1):159-64. doi: 10.1016/j.humpath.2014.10.005. Epub 2014 Oct 18.

本文引用的文献

1
Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease.全脑全脊髓照射治疗中枢神经系统 Erdheim-Chester 病继发的呼吸衰竭。
Radiat Oncol J. 2022 Jun;40(2):162-168. doi: 10.3857/roj.2021.01074. Epub 2022 May 20.
2
IgG4-Related Disease Presenting as Hypertrophic Pachymeningitis.表现为肥厚性硬脑膜炎的IgG4相关性疾病。
Cureus. 2022 Feb 2;14(2):e21850. doi: 10.7759/cureus.21850. eCollection 2022 Feb.
3
Lymphomatoid granulomatosis of the central nervous system (CNS-LYG) posing a management challenge.
中枢神经系统淋巴瘤样肉芽肿病(CNS-LYG)带来了治疗挑战。
Clin Case Rep. 2021 Sep 7;9(9):e04808. doi: 10.1002/ccr3.4808. eCollection 2021 Sep.
4
High frequency of clonal hematopoiesis in Erdheim-Chester disease.高频克隆性造血见于 Erdheim-Chester 病。
Blood. 2021 Jan 28;137(4):485-492. doi: 10.1182/blood.2020005101.
5
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy.双重BRAF/MEK阻断可恢复BRAF抑制剂单药治疗后BRAF突变型 Erdheim-Chester病患者的中枢神经系统反应。
Neurooncol Adv. 2020 Mar 3;2(1):vdaa024. doi: 10.1093/noajnl/vdaa024. eCollection 2020 Jan-Dec.
6
MR imaging of cerebral involvement of Rosai-Dorfman disease: a single-centre experience with review of the literature.磁共振成像在罗道氏病脑内侵犯中的应用:单中心经验并文献复习
Radiol Med. 2021 Jan;126(1):89-98. doi: 10.1007/s11547-020-01226-7. Epub 2020 May 26.
7
A rare differential for sinusitis and visual loss.鼻窦炎与视力丧失的一种罕见鉴别诊断。
Ann R Coll Surg Engl. 2020 Feb;102(2):e42-e44. doi: 10.1308/rcsann.2019.0130. Epub 2019 Sep 20.
8
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.厄德里希-切斯特病诊断与临床管理的共识指南。
Blood. 2014 Jul 24;124(4):483-92. doi: 10.1182/blood-2014-03-561381. Epub 2014 May 21.
9
Erdheim-Chester Disease: a comprehensive review of the literature.厄德海姆-切斯特病:文献综述。
Orphanet J Rare Dis. 2013 Sep 8;8:137. doi: 10.1186/1750-1172-8-137.
10
Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases.T 细胞移植后淋巴组织增生性疾病的危险因素和预后:163 例再评估。
Transplantation. 2013 Feb 15;95(3):479-88. doi: 10.1097/TP.0b013e3182762e07.